Tag: Prescription Drugs
Fixed-Duration Ibrutinib Plus Venetoclax Beneficial for Leukemia
Overall response rates >95 percent, regardless of high-risk features; 36-month PFS 88 and 92 percent for those with, without high-risk features
Outpatient Metformin Treatment Reduces Incidence of Long COVID
Beneficial effect of metformin consistent across subgroups
Valbenazine Yields Improvement in Chorea in Huntington Disease
Improvement seen in Unified Huntington's Disease Rating Scale Total Maximal Chorea with valbenazine versus placebo
ASCO: Adding Atezolizumab to Cabozantinib No Benefit in Advanced Renal Cancer
No improvement seen in disease progression or death, and increase seen in serious adverse events with atezolizumab + cabozantinib
ASCO: Cilta-Cel Beneficial for Lenalidomide-Refractory Multiple Myeloma
Single cilta-cel infusion results in lower risk of disease progression or death compared with standard care
ASCO: Drug Combo Ups Progression-Free Survival for Metastatic Prostate Cancer
Improvement in radiographic progression-free survival seen for talazoparib plus enzalutamide as first-line treatment
Semaglutide Better Than Liraglutide for Post-Bariatric Surgery Weight Recurrence
Findings seen for weekly semaglutide versus daily liraglutide regardless of procedure type
Semaglutide Reduces BMI Category for Adolescents With Obesity
Improvement of one or more BMI category seen for majority of participants receiving semaglutide
Spironolactone Found to Improve Acne in Adult Women
Mean quality-of-life symptoms favor spironolactone at 12 and 24 weeks; more participants report acne improvement with spironolactone
Nirmatrelvir-Ritonavir Effective for Outpatient Treatment of COVID-19
Reduces 30-day risk for hospitalization and death, while only death was reduced in association with molnupiravir
